1. Home
  2. BNED vs ALDX Comparison

BNED vs ALDX Comparison

Compare BNED & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barnes & Noble Education Inc

BNED

Barnes & Noble Education Inc

HOLD

Current Price

$9.15

Market Cap

284.0M

ML Signal

HOLD

Logo Aldeyra Therapeutics Inc.

ALDX

Aldeyra Therapeutics Inc.

HOLD

Current Price

$1.27

Market Cap

317.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNED
ALDX
Founded
1965
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
284.0M
317.7M
IPO Year
2015
2014

Fundamental Metrics

Financial Performance
Metric
BNED
ALDX
Price
$9.15
$1.27
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$9.50
AVG Volume (30 Days)
232.2K
2.1M
Earning Date
06-04-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
40.43
EPS
0.39
N/A
Revenue
$1,610,170,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$123.43
P/E Ratio
$24.13
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.90
$1.07
52 Week High
$12.19
$6.87

Technical Indicators

Market Signals
Indicator
BNED
ALDX
Relative Strength Index (RSI) 59.31 18.24
Support Level $8.23 N/A
Resistance Level $9.52 $5.75
Average True Range (ATR) 0.50 0.43
MACD 0.07 -0.31
Stochastic Oscillator 68.42 5.03

Price Performance

Historical Comparison
BNED
ALDX

About BNED Barnes & Noble Education Inc

Barnes & Noble Education Inc is a contract operator of physical and virtual bookstores for college and university campuses and K-12 institutions across the United States. The company is also a textbook wholesaler and inventory management hardware and software provider. It offers course materials through physical and online bookstores, including new and used print textbooks, rental options, digital textbooks, and publisher-hosted digital courseware. Products are also offered directly to students through Textbooks.com. The majority of the company's revenue is derived from the sale of products through its bookstore locations, including virtual bookstores, and the bookstore affiliated e-commerce websites.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: